Skip to main content
Caplight Logo









IntelliProve

IntelliProve

Private
BelgiumHealthcare & Life Scienceshttps://intelliprove.com/

Last Round

Seed

Jan 22, 2025

Total Funding Raised

$2.35M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

IntelliProve is a health technology company that provides AI-driven facial scanning software to measure physiological and mental health biomarkers for digital health and corporate wellbeing platforms.

Sector

Healthcare & Life Sciences

Verticals

Computer Vision, Healthcare Analytics, Mental Health, InsurTech

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Infrastructure

Keywords

contactless health assessmentfacial scanningrPPGremote photoplethysmographyhealth APIbiometric health monitoringdigital healthcomputer visionAI health diagnosticsinsurtechvital signs monitoringvitals from videotelehealth toolsB2B SaaSremote patient monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

IntelliProve Comparables

Compare IntelliProve with similar companies based on industry and business-model similarity.

IntelliProve comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shen AI
91%
i-Virtual
88%
Lifelight
87%

IntelliProve Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 22, 2025
SeedNov 15, 2022
AcceleratorSep 1, 2021

Key People

Founding team and executive leadership

Brecht Dhuyvetters

Co-Founder & CPO

Founding Team

Joeri Tulkens

Co-Founder CEO

Founding Team

IntelliProve Investors

Notable investors and investment history

IntelliProve investors
InvestorRounds
BirdhouseAccelerator
imec.istartAccelerator
Miles AheadSeed
VLAIOSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 13, 2026

    Monthly visitors grew 141% MoM, reaching 12.9K.

  • Apr 16, 2026

    Monthly visitors increased 898% MoM, reaching 12K.

IntelliProve Filings

Explore SEC and related filing metadata, where available.

IntelliProve filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about IntelliProve's valuation, stock price, and market status.

Is IntelliProve a public or private company?

IntelliProve is a private company.

What is the current stock price of IntelliProve?

IntelliProve is a private company, so its shares have no public market price. Caplight tracks IntelliProve's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is IntelliProve worth (valuation)?

Valuation information for IntelliProve is not publicly available.

Can I buy IntelliProve stock?

IntelliProve shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was IntelliProve's last funding round?

IntelliProve's most recent funding round was Seed on January 22, 2025.

Who are the main investors in IntelliProve?

Key investors in IntelliProve include Birdhouse, imec.istart, Miles Ahead, VLAIO.

Will IntelliProve IPO soon?

No public IPO plans have been announced for IntelliProve.

How can I track IntelliProve secondary market activity?

Caplight tracks bids, offers, and trades in IntelliProve's shares on secondary markets.

Firmographic Details

HeadquartersBelgium
Employee Range14
Year Founded2021
Last FundingJan 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?